Patient and physician perspectives of systemic lupus erythematosus flare: A qualitative study.


Journal

The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984

Informations de publication

Date de publication:
15 Dec 2023
Historique:
medline: 16 12 2023
pubmed: 16 12 2023
entrez: 15 12 2023
Statut: aheadofprint

Résumé

Systemic lupus erythematosus (SLE) flares are associated with increased damage and decreased health-related quality of life. We hypothesized there is discordance between physicians' and patients' views of lupus flare. In this study, we aimed to explore patient and physician descriptions of SLE flares. We conducted a qualitative descriptive study using in-depth interviews with a purposeful sample of patients with SLE (1997 ACR or SLICC criteria) and practicing rheumatologists. Interviews were audio-recorded, transcribed, and analyzed using applied thematic analysis. Forty-two patient participants living with SLE, representing a range of lupus activity, completed interviews. The majority described flare symptoms as joint pain, fatigue, and skin issues lasting several days. Few included objective signs or laboratory measures, when available, as features of flare.We interviewed 13 rheumatologists from 10 academic and 3 community settings. The overwhelming majority defined flare as increased or worsening lupus disease activity with slightly more than half requiring objective findings. Around half of the rheumatologists included fatigue, pain or other patient-reported symptoms. Patients and physicians described flare differently. Participants with SLE perceive flares as several days of fatigue, pain, and features. Providers define flares as periods of increased clinical SLE activity. Our findings suggest the current definition of flare may be insufficient to integrate both perceptions. Further study is needed to understand the pathophysiology of patient flares and the best way to incorporate patients' perspectives into clinical assessments.

Identifiants

pubmed: 38101916
pii: jrheum.2023-0721
doi: 10.3899/jrheum.2023-0721
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Jennifer L Rogers (JL)

Jennifer L. Rogers, MD, Division of Rheumatology and Immunology, Duke University School of Medicine.

Megan E B Clowse (MEB)

Megan E.B. Clowse, MD, MPH, Division of Rheumatology and Immunology, Duke University School of Medicine.

Kevin McKenna (K)

Kevin McKenna, MPH, Population Health Sciences, Duke University School of Medicine.

Summer Starling (S)

Summer Starling, DrPH, MPH, Population Health Sciences, Duke University School of Medicine.

Teresa Swezey (T)

Teresa Swezey, PhD, Population Health Sciences, Duke University School of Medicine.

Nneka Molokwu (N)

Nneka Molokwu, MSW, Population Health Sciences, Duke University School of Medicine.

Amy Corneli (A)

Amy Corneli, PhD, MPH, Population Health Sciences, Duke University School of Medicine.

David S Pisetsky (DS)

David S. Pisetsky, MD, PhD, Division of Rheumatology and Immunology, Duke University School of Medicine, Durham VA Medical Center.

Kai Sun (K)

Kai Sun, MD, MS, Division of Rheumatology and Immunology, Duke University School of Medicine.

Lisa G Criscione-Schreiber (LG)

Lisa G. Criscione-Schreiber, MD, MEd, Division of Rheumatology and Immunology, Duke University School of Medicine.

Rebecca E Sadun (RE)

Rebecca E. Sadun, MD, PhD, Division of Rheumatology and Immunology, Duke University School of Medicine.

Mithu Maheswaranthan (M)

Mithu Maheswaranthan, MD, Division of Rheumatology and Immunology, Duke University School of Medicine.

Dana Burshell (D)

Dana Burshell, MPH, Division of Rheumatology and Immunology, Duke University School of Medicine.

Jayanth Doss (J)

Jayanth Doss, MD, MPH, Division of Rheumatology and Immunology, Duke University School of Medicine.

Amanda M Eudy (AM)

Amanda M. Eudy, PhD, Division of Rheumatology and Immunology, Duke University School of Medicine.

Classifications MeSH